Skip to Content

Mirikizumab Improves Fatigue Abdominal Pain and Stool Frequency in Crohn’s Disease

Results presented at UEG Week 2025 in Berlin underscore the durable efficacy of mirikizumab in reducing symptom burden and improving quality of life in patients with Crohn’s disease.

Gastroenterologist Doctor Consulting Woman In Clinic. Health And Medicine

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top